DOCS Relative Valuation
DOCS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DOCS is overvalued; if below, it's undervalued.
Historical Valuation
Doximity Inc (DOCS) is now in the Fair zone, suggesting that its current forward PE ratio of 41.54 is considered Fairly compared with the five-year average of 58.86. The fair price of Doximity Inc (DOCS) is between 25.69 to 138.06 according to relative valuation methord.
Relative Value
Fair Zone
25.69-138.06
Current Price：60.20
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
10.50
P/B
Median3y
7.33
Median5y
9.17
2.42
FCF Yield
Median3y
2.85
Median5y
2.42
Competitors Valuation Multiple
The average P/S ratio for DOCS's competitors is 11.38, providing a benchmark for relative valuation. Doximity Inc Corp (DOCS) exhibits a P/S ratio of 18.02, which is 58.28% above the industry average. Given its robust revenue growth of 17.14%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Doximity Inc (DOCS) currently overvalued or undervalued?
What is Doximity Inc (DOCS) fair value?
How does DOCS's valuation metrics compare to the industry average?
What is the current P/B ratio for Doximity Inc (DOCS) as of Jul 13 2025?
What is the current FCF Yield for Doximity Inc (DOCS) as of Jul 13 2025?
What is the current Forward P/E ratio for Doximity Inc (DOCS) as of Jul 13 2025?